Board meeting on October 12, 2026 to consider fund raising via NCDs and shareholder approval

Jubilant Pharmova has informed the exchanges that a Board meeting is scheduled for Monday, October 12, 2026.

Wed 7 Oct 2026

Board meeting date

Monday, October 12, 2026

Agenda - fund raising

raising of funds through the issuance of Non-Convertible Debentures (NCDs) and/or such other securities

Agenda - shareholder approval

approving the seeking of shareholders' approval, as may be required in this regard

The company has given prior notice to the exchanges about its next Board meeting.

Board meeting date

• The meeting of the Board of Directors of Jubilant Pharmova Limited is scheduled for Monday, October 12, 2026.

What the Board will consider

• Raising of funds through the issuance of Non-Convertible Debentures (NCDs) and/or such other securities as may be permitted under applicable laws.
• Approval for seeking shareholders' approval, as may be required in this regard.

What are NCDs, in simple terms

An NCD, or Non-Convertible Debenture, is a debt instrument. A company that issues NCDs borrows money from investors and pays interest on it, and repays the principal at maturity. Unlike convertible debentures, NCDs do not convert into equity shares. So a fund raise through NCDs is a borrowing route rather than a route that issues new shares to investors.

What the update says and does not say

The intimation states that the Board will "consider and approve" the fund raising and the seeking of shareholders' approval. The wording used is about what the Board will consider at the meeting. The intimation is issued as prior notice of the Board meeting.

How to read this

• The communication is a notice of a scheduled Board meeting, not the outcome of one.
• The item relates to fund raising through debt instruments and/or other permitted securities, along with a possible shareholders' approval.
• Investors typically wait for the actual Board decision, and for the details that accompany it, to understand the size and terms of any such issuance.

The company has also said this information is available on its website, www.jubilantpharmova.com.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.